Guest-Barbara_*
12-11-2004, 07:53 PM
Clodronate (a non nitrogen-containing bisphosphonate) has been used in Stage IV BC for for some time but recently a study was completed using it in primary breast cancer and it was shown to reduce the incidence of bone metastases and improve survival rates. The study concluded that further trials are needed to confirm the results to date and to determine the optimal duration of treatment.
I was wondering if any of you Stage II and III gals have asked your oncologist for Chodronate off label. It is speculated that bone mets often lead to other mets as blood cells from the bone marrow carry the cancer to the liver and lung, etc. thus the prevention of bone mets could signifcantly reduce re-occurences.
I want to broach the topic with my oncologist and was wondering if any of you may have already done so.
I was wondering if any of you Stage II and III gals have asked your oncologist for Chodronate off label. It is speculated that bone mets often lead to other mets as blood cells from the bone marrow carry the cancer to the liver and lung, etc. thus the prevention of bone mets could signifcantly reduce re-occurences.
I want to broach the topic with my oncologist and was wondering if any of you may have already done so.